Joshua Brody/LinkedIn
Apr 24, 2025, 12:10
Joshua Brody: Quick summary on using CRISPR to edit T-cells
Joshua Brody, Director of Lymphoma Immunotherapy Program and Associate Professor of Division of Hematology and Oncology at Icahn School of Medicine at Mount Sinai, shared a post on LinkedIn about he co-authored with colleagues published in Methods in Cell Biology:
“Cool, quick summary of by Moah Sohn on how to CRISPR edit T-cells to understand and improve them for cancer immunotherapy.”
“Mouse and human T cell Cas9-RNP/nucleofection-mediated gene-editing”
Authors: Moah Sohn, Gvantsa Pantsulaia, Joshua Brody.
More posts featuring Joshua Brody.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 8, 2025, 08:57
Sep 8, 2025, 08:22
Sep 8, 2025, 08:21
Sep 8, 2025, 08:19
Sep 8, 2025, 08:15
Sep 8, 2025, 08:13
Sep 8, 2025, 08:02